New breast cancer vaccine provides evidence of immunotherapy in preventing disease re

['lizbeth]

If we are fortunate enough to have a Phase III trial for the Her2 higher expressors it will be with all new enrollees. I hope that we Phase IIs will continue to be followed.

When I enrolled in the Phase II, I had expected a Phase III to start for the Her2 survivors. Along the way, the primary companies switched focus from us to the lower expressors. There are Phase III trials currently for Her2 1+ and Her2 2+, but nothing for the Her2 3+ that I am aware of.

I thought that Dr. Mittendorf was working on something for the higher expressors with E75, and I hope so. I would also like to see Antigen Express start a Phase III for the higher expressors with AE37, and Dr. Peoples with GP2.

When I enrolled in the AE37/GP2 trial the window was to be enrolled 6 months from the completion of Herceptin.